Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.125 | Study on Comparison of the clinical outcomes of extracorporeal shock wave lithotripsy for lower ureteric stone treated at different patient position | Prof. Ng Chi Fai |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2012.399 | Health Exhibition Health Check Survey | Prof. Ng Chi Fai |
| 2014.096 | A prospective study to investigate the effect of stepwise voltage escalation on treatment outcome in extracorporeal shockwave lithotripsy of renal calculi | Prof. Ng Chi Fai |
| 2010.392 | A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi | Prof Ng Chi Fai |
| 2012.105 | ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC | Prof. NG Chi Fai |
| 2010.494 | A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy | Prof. Ng Chi Fai |
| 2009.528 | A Phase 2B, Randomized, Double-blind, Placebo-Controlled, Dose Ranging Study Evaluating the Efficacy and Safety of Tanezumab for the Treatment of Moderate to Severe Pain Associated with Interstitial Cystitis / Painful Bladder Syndrome (IC/PBS) | Dr. Ng Chi Fai |
| 2010.465 | A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Chemotherapy-Na_ve Metastatic Castration-Resistant Prostate Cancer | Professor Ng Chi Fai |
| 2010.507 | The role of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia. | Prof. Ng Chi Fai |
| 2010.577 | Prospective study of the effect of androgen deprivation therapy (ADT) in male patients suffered prostate cancer in Chinese Population | Prof. NG Chi Fai |
| 2013.494 | PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | Prof. NG Chi Fai |
| 2009.620 | Strategies To Prevent Renal Trauma | Prof. Ng Chi Fai |
| 2020.603 | To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2019.211 | To establish a reproducible organoid culture model with human kidney cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.323 | Can transperineal prostate biopsy replace transrectal prostate biopsy? Hong Kong experience of the first 100 cases of transperineal prostate biopsy |
Prof. NG Chi Fai 吳志輝 |
| 2019.491 | Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) |
Prof. NG Chi Fai 吳志輝 |
| 2018.280 | A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.611 | To identify potential new urine marker panel for cancer screening |
Prof. NG Chi Fai 吳志輝 |
| 2019.166 | A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma |
Prof. NG Chi Fai 吳志輝 |
| 2018.541 | SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.063 | To investigate the diagnostic accuracy of exosomal microRNA in predicting the aggressiveness of prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2018.376 | To identify potential new urine markers for the screening of prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.017 | To investigate the possible underlying causes for patient with nocturia in Hong Kong patients |
Prof. NG Chi Fai 吳志輝 |
| 2020.185 | To compare Spermine Risk Score and Prostate Health Index in diagnosing prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2020.050 | To evaluate the performance of a urine spermine measuring device in predicting prostate biopsy result |
Prof. NG Chi Fai 吳志輝 |
| 2019.534 | To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms |
Prof. NG Chi Fai 吳志輝 |
| 2020.454 | A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of novel anti-hormonal therapy (NAH) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of NAH |
Prof. NG Chi Fai 吳志輝 |
| 2019.662 | The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2019.400 | A retrospective review of the association of baseline characteristics of male patients presented with lower urinary tract and long term clinical outcomes |
Prof. NG Chi Fai 吳志輝 |
| 2020.058 | Characterising and Fingerprinting Biomarkers of Urolithiasis: A Case Control Study |
Prof. NG Chi Fai 吳志輝 |
| 2018.276 | A prospective randomized study to investigate the effect of extracorporeal shockwave lithotripsy on blood pressure control in patients with hypertension – a pilot study |
Prof. NG Chi Fai 吳志輝 |
| 2019.378 | To identify potential new genetic marker for diagnosis of cystinuria. |
Prof. NG Chi Fai 吳志輝 |
| 2015.551 | A retrospective review of the characteristics and management outcomes of male patients presented with erectile dysfunction in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2016.540 | To investigate the effect of perioperative factors on the complications and readmission rate after endourological procedures for urinary calculi |
Dr. NG Chi Fai 吳志輝 |
| 2016.508 | Understanding the role of purinergic signalling in the human bladder |
Dr. NG Chi Fai 吳志輝 |
| 2016.386 | Prostate cancer Research International: Active Surveillance (PRIAS) in Hong Kong men |
Prof. NG Chi Fai 吳志輝 |
| 2016.373 | Difference in quality of life (QOL) between localized prostate cancer patients who have completed prostatectomy or radiotherapy reflected by patient reported outcomes (PROs): A descriptive study in cross-sectional design |
Prof. NG Chi Fai 吳志輝 |
| 2016.428 | A Multi-Center, International Registry to evaluate the treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment types and Outcomes. |
Dr. NG Chi Fai 吳志輝 |
| 2017.583 | The Investigation of the use of canines in the detection of prostate cancer |
Dr. NG Chi Fai 吳志輝 |
| 2016.396 | A comprehensive prospective assessment of the physical and biological effects of bladder cancer |
Prof. NG Chi Fai 吳志輝 |
| 2013.593 | A Randomized, Double-Blind, Parallel-Group, Active-Controlled, Multi-center Study to Evaluate the Long-Term Safety and Efficacy of Combination of Solifenacin Succinate with Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in Subjects with Overactive Bladder | Prof. NG Chi Fai |
| 2016.392 | The Effect of Androgen Deprivation Therapy on Bone Mineral Density in Chinese Men with Prostate Cancer |
Prof. NG Chi Fai 吳志輝 |
| 2015.444 | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population |
Dr. NG Chi Fai 吳志輝 |
| 2016.184 | A retrospective review of the characteristics and clinical outcome of living kidney transplant donor in Hong Kong |
Dr. NG Chi Fai 吳志輝 |
| 2016.105 | A retrospective review of the clinical and pathological outcome of patients receiving transrectal ultrasound with prostate biopsy in Hong Kong |
Dr. NG Chi Fai 吳志輝 |
| 2016.106 | A prospective study to assess the patient reported outcomes during the management of prostate cancer in Hong Kong |
Prof. NG Chi Fai 吳志輝 |
| 2014.100 | A cross-sectional survey for the prevalence of late-onset hypogonadism among 40-80 years old males in Hong Kong | Prof. NG Chi Fai |
| 2014.467 | Urinary metabolic prognostic markers in prostate cancer | Prof. NG Chi Fai |
| 2015.182 | Factors Affecting Cancer Survivors' Work Ability |
Prof. NG Chi Fai 吳志輝 |
Page 177 of 265.